Proteins > NAD-dependent protein deacetylase sirtuin-2
Page last updated: 2024-08-07 17:18:26
NAD-dependent protein deacetylase sirtuin-2
An NAD-dependent protein deacetylase sirtuin-2 that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q8IXJ6]
Synonyms
EC 2.3.1.286;
Regulatory protein SIR2 homolog 2;
SIR2-like protein 2
Research
Bioassay Publications (58)
Timeframe | Studies on this Protein(%) | All Drugs % |
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 13 (22.41) | 29.6817 |
2010's | 38 (65.52) | 24.3611 |
2020's | 7 (12.07) | 2.80 |
Compounds (34)
Drugs with Inhibition Measurements
Drugs with Activation Measurements
Drug | Taxonomy | Measurement | Average (mM) | Bioassay(s) | Publication(s) |
resveratrol | Homo sapiens (human) | EC50 | 300.0000 | 1 | 1 |
srt1460 | Homo sapiens (human) | EC50 | 300.0000 | 1 | 1 |
srt1720 | Homo sapiens (human) | EC50 | 18.5800 | 2 | 2 |
srt2183 | Homo sapiens (human) | EC50 | 300.0000 | 1 | 1 |
Structure-Reactivity Relationships on Substrates and Inhibitors of the Lysine Deacylase Sirtuin 2 from Journal of medicinal chemistry, , 10-10, Volume: 62, Issue:19, 2019
Novel Lysine-Based Thioureas as Mechanism-Based Inhibitors of Sirtuin 2 (SIRT2) with Anticancer Activity in a Colorectal Cancer Murine Model.Journal of medicinal chemistry, , 04-25, Volume: 62, Issue:8, 2019
Development of Peptide-Based Sirtuin Defatty-Acylase Inhibitors Identified by the Fluorescence Probe, SFP3, That Can Efficiently Measure Defatty-Acylase Activity of Sirtuin.Journal of medicinal chemistry, , 06-13, Volume: 62, Issue:11, 2019
Aminothiazoles as Potent and Selective Sirt2 Inhibitors: A Structure-Activity Relationship Study.Journal of medicinal chemistry, , Feb-25, Volume: 59, Issue:4, 2016
Design, synthesis and structure-activity relationship studies of novel sirtuin 2 (SIRT2) inhibitors with a benzamide skeleton.Bioorganic & medicinal chemistry, , Jan-15, Volume: 23, Issue:2, 2015
Functionalized tetrahydro-1H-pyrido[4,3-b]indoles: a novel chemotype with Sirtuin 2 inhibitory activity.European journal of medicinal chemistry, , Mar-06, Volume: 92, 2015
Discovery of potent and selective sirtuin 2 (SIRT2) inhibitors using a fragment-based approach.Journal of medicinal chemistry, , Oct-23, Volume: 57, Issue:20, 2014
Inhibitors of the NAD(+)-Dependent Protein Desuccinylase and Demalonylase Sirt5.ACS medicinal chemistry letters, , Dec-13, Volume: 3, Issue:12, 2012
Identification of a cell-active non-peptide sirtuin inhibitor containing N-thioacetyl lysine.Bioorganic & medicinal chemistry letters, , Oct-01, Volume: 19, Issue:19, 2009
Structure-activity studies on splitomicin derivatives as sirtuin inhibitors and computational prediction of binding mode.Journal of medicinal chemistry, , Mar-13, Volume: 51, Issue:5, 2008
Adenosine mimetics as inhibitors of NAD+-dependent histone deacetylases, from kinase to sirtuin inhibition.Journal of medicinal chemistry, , Dec-14, Volume: 49, Issue:25, 2006
An in silico approach to discovering novel inhibitors of human sirtuin type 2.Journal of medicinal chemistry, , Dec-02, Volume: 47, Issue:25, 2004
Synthesis and biological activity of splitomicin analogs targeted at human NAD(+)-dependent histone deacetylases (sirtuins).Bioorganic & medicinal chemistry, , Jun-15, Volume: 19, Issue:12, 2011
Adenosine mimetics as inhibitors of NAD+-dependent histone deacetylases, from kinase to sirtuin inhibition.Journal of medicinal chemistry, , Dec-14, Volume: 49, Issue:25, 2006
Discovery of thieno[3,2-d]pyrimidine-6-carboxamides as potent inhibitors of SIRT1, SIRT2, and SIRT3.Journal of medicinal chemistry, , May-09, Volume: 56, Issue:9, 2013
Inhibitors of the NAD(+)-Dependent Protein Desuccinylase and Demalonylase Sirt5.ACS medicinal chemistry letters, , Dec-13, Volume: 3, Issue:12, 2012
Design, synthesis and structure-activity relationship studies of novel sirtuin 2 (SIRT2) inhibitors with a benzamide skeleton.Bioorganic & medicinal chemistry, , Jan-15, Volume: 23, Issue:2, 2015
SIRT1 modulation as a novel approach to the treatment of diseases of aging.Journal of medicinal chemistry, , Jan-27, Volume: 54, Issue:2, 2011
An overview of Sirtuins as potential therapeutic target: Structure, function and modulators.European journal of medicinal chemistry, , Jan-01, Volume: 161, 2019
Pharmaceutical significance of azepane based motifs for drug discovery: A critical review.European journal of medicinal chemistry, , Jan-15, Volume: 162, 2019
Design, synthesis and structure-activity relationship studies of novel sirtuin 2 (SIRT2) inhibitors with a benzamide skeleton.Bioorganic & medicinal chemistry, , Jan-15, Volume: 23, Issue:2, 2015
Design and Evaluation of 3-(Benzylthio)benzamide Derivatives as Potent and Selective SIRT2 Inhibitors.ACS medicinal chemistry letters, , May-14, Volume: 6, Issue:5, 2015
Development and characterization of 3-(benzylsulfonamido)benzamides as potent and selective SIRT2 inhibitors.European journal of medicinal chemistry, , Apr-09, Volume: 76, 2014
The Discovery of Novel 10,11-Dihydro-5H-dibenz[b,f]azepine SIRT2 Inhibitors.MedChemComm, , Mar-01, Issue:3, 2012
Computer- and structure-based lead design for epigenetic targets.Bioorganic & medicinal chemistry, , Jun-15, Volume: 19, Issue:12, 2011
N,N'-Bisbenzylidenebenzene-1,4-diamines and N,N'-Bisbenzylidenenaphthalene-1,4-diamines as Sirtuin Type 2 (SIRT2) Inhibitors.Journal of medicinal chemistry, , Dec-28, Volume: 49, Issue:26, 2006
An in silico approach to discovering novel inhibitors of human sirtuin type 2.Journal of medicinal chemistry, , Dec-02, Volume: 47, Issue:25, 2004
Recent applications of hydantoin and thiohydantoin in medicinal chemistry.European journal of medicinal chemistry, , Feb-15, Volume: 164, 2019
Thienopyrimidinone Based Sirtuin-2 (SIRT2)-Selective Inhibitors Bind in the Ligand Induced Selectivity Pocket.Journal of medicinal chemistry, , 03-09, Volume: 60, Issue:5, 2017
Discovery and Characterization of R/S-N-3-Cyanophenyl-N'-(6-tert-butoxycarbonylamino-3,4-dihydro-2,2-dimethyl-2H-1-benzopyran-4-yl)urea, a New Histone Deacetylase Class III Inhibitor Exerting Antiproliferative Activity against Cancer Cell Lines.Journal of medicinal chemistry, , 06-08, Volume: 60, Issue:11, 2017
How much successful are the medicinal chemists in modulation of SIRT1: A critical review.European journal of medicinal chemistry, , Aug-25, Volume: 119, 2016
Discovery of thieno[3,2-d]pyrimidine-6-carboxamides as potent inhibitors of SIRT1, SIRT2, and SIRT3.Journal of medicinal chemistry, , May-09, Volume: 56, Issue:9, 2013
The Discovery of Novel 10,11-Dihydro-5H-dibenz[b,f]azepine SIRT2 Inhibitors.MedChemComm, , Mar-01, Issue:3, 2012
Creation of an HDAC-based yeast screening method for evaluation of marine-derived actinomycetes: discovery of streptosetin A.Journal of natural products, , Dec-28, Volume: 75, Issue:12, 2012
Inhibitors of the NAD(+)-Dependent Protein Desuccinylase and Demalonylase Sirt5.ACS medicinal chemistry letters, , Dec-13, Volume: 3, Issue:12, 2012
SIRT1 modulation as a novel approach to the treatment of diseases of aging.Journal of medicinal chemistry, , Jan-27, Volume: 54, Issue:2, 2011
After the grape rush: sirtuins as epigenetic drug targets in neurodegenerative disorders.Bioorganic & medicinal chemistry, , Jun-15, Volume: 19, Issue:12, 2011
Characterization of sirtuin inhibitors in nematodes expressing a muscular dystrophy protein reveals muscle cell and behavioral protection by specific sirtinol analogues.Journal of medicinal chemistry, , Feb-11, Volume: 53, Issue:3, 2010
Structure-activity studies on splitomicin derivatives as sirtuin inhibitors and computational prediction of binding mode.Journal of medicinal chemistry, , Mar-13, Volume: 51, Issue:5, 2008
Adenosine mimetics as inhibitors of NAD+-dependent histone deacetylases, from kinase to sirtuin inhibition.Journal of medicinal chemistry, , Dec-14, Volume: 49, Issue:25, 2006
N,N'-Bisbenzylidenebenzene-1,4-diamines and N,N'-Bisbenzylidenenaphthalene-1,4-diamines as Sirtuin Type 2 (SIRT2) Inhibitors.Journal of medicinal chemistry, , Dec-28, Volume: 49, Issue:26, 2006
Design, synthesis, and biological evaluation of sirtinol analogues as class III histone/protein deacetylase (Sirtuin) inhibitors.Journal of medicinal chemistry, , Dec-01, Volume: 48, Issue:24, 2005
An in silico approach to discovering novel inhibitors of human sirtuin type 2.Journal of medicinal chemistry, , Dec-02, Volume: 47, Issue:25, 2004
[no title available]ACS medicinal chemistry letters, , Mar-11, Volume: 12, Issue:3, 2021
How much successful are the medicinal chemists in modulation of SIRT1: A critical review.European journal of medicinal chemistry, , Aug-25, Volume: 119, 2016
[no title available]Bioorganic & medicinal chemistry letters, , 11-01, Volume: 26, Issue:21, 2016
Benzimidazoles as new scaffold of sirtuin inhibitors: green synthesis, in vitro studies, molecular docking analysis and evaluation of their anti-cancer properties.European journal of medicinal chemistry, , Aug-18, Volume: 83, 2014
Development of pyrazolone and isoxazol-5-one cambinol analogues as sirtuin inhibitors.Journal of medicinal chemistry, , Apr-24, Volume: 57, Issue:8, 2014
Synthesis and evaluation of novel benzimidazole derivatives as sirtuin inhibitors with antitumor activities.Bioorganic & medicinal chemistry, , Jan-15, Volume: 22, Issue:2, 2014
Discovery of thieno[3,2-d]pyrimidine-6-carboxamides as potent inhibitors of SIRT1, SIRT2, and SIRT3.Journal of medicinal chemistry, , May-09, Volume: 56, Issue:9, 2013
Benzodeazaoxaflavins as sirtuin inhibitors with antiproliferative properties in cancer stem cells.Journal of medicinal chemistry, , Sep-27, Volume: 55, Issue:18, 2012
Inhibitors of the NAD(+)-Dependent Protein Desuccinylase and Demalonylase Sirt5.ACS medicinal chemistry letters, , Dec-13, Volume: 3, Issue:12, 2012
SIRT1 modulation as a novel approach to the treatment of diseases of aging.Journal of medicinal chemistry, , Jan-27, Volume: 54, Issue:2, 2011
Simplification of the tetracyclic SIRT1-selective inhibitor MC2141: coumarin- and pyrimidine-based SIRT1/2 inhibitors with different selectivity profile.Bioorganic & medicinal chemistry, , Jun-15, Volume: 19, Issue:12, 2011
Novel cambinol analogs as sirtuin inhibitors: synthesis, biological evaluation, and rationalization of activity.Journal of medicinal chemistry, , May-14, Volume: 52, Issue:9, 2009
An overview of Sirtuins as potential therapeutic target: Structure, function and modulators.European journal of medicinal chemistry, , Jan-01, Volume: 161, 2019
Sirtuin 2 inhibitors rescue alpha-synuclein-mediated toxicity in models of Parkinson's disease.Science (New York, N.Y.), , Jul-27, Volume: 317, Issue:5837, 2007
Discovery of Dihydro-1,4-Benzoxazine Carboxamides as Potent and Highly Selective Inhibitors of Sirtuin-1.Journal of medicinal chemistry, , 05-13, Volume: 64, Issue:9, 2021
Synthesis of indole inhibitors of silent information regulator 1 (SIRT1), and their evaluation as cytotoxic agents.European journal of medicinal chemistry, , Sep-15, Volume: 202, 2020
Sensitive fluorogenic substrates for sirtuin deacylase inhibitor discovery.European journal of medicinal chemistry, , Apr-15, Volume: 192, 2020
Novel Lysine-Based Thioureas as Mechanism-Based Inhibitors of Sirtuin 2 (SIRT2) with Anticancer Activity in a Colorectal Cancer Murine Model.Journal of medicinal chemistry, , 04-25, Volume: 62, Issue:8, 2019
Discovery and Characterization of R/S-N-3-Cyanophenyl-N'-(6-tert-butoxycarbonylamino-3,4-dihydro-2,2-dimethyl-2H-1-benzopyran-4-yl)urea, a New Histone Deacetylase Class III Inhibitor Exerting Antiproliferative Activity against Cancer Cell Lines.Journal of medicinal chemistry, , 06-08, Volume: 60, Issue:11, 2017
Discovery of bicyclic pyrazoles as class III histone deacetylase SIRT1 and SIRT2 inhibitors.Bioorganic & medicinal chemistry letters, , Jun-15, Volume: 25, Issue:12, 2015
Discovery of potent and selective sirtuin 2 (SIRT2) inhibitors using a fragment-based approach.Journal of medicinal chemistry, , Oct-23, Volume: 57, Issue:20, 2014
Discovery of thieno[3,2-d]pyrimidine-6-carboxamides as potent inhibitors of SIRT1, SIRT2, and SIRT3.Journal of medicinal chemistry, , May-09, Volume: 56, Issue:9, 2013
The Discovery of Novel 10,11-Dihydro-5H-dibenz[b,f]azepine SIRT2 Inhibitors.MedChemComm, , Mar-01, Issue:3, 2012
Benzodeazaoxaflavins as sirtuin inhibitors with antiproliferative properties in cancer stem cells.Journal of medicinal chemistry, , Sep-27, Volume: 55, Issue:18, 2012
Inhibitors of the NAD(+)-Dependent Protein Desuccinylase and Demalonylase Sirt5.ACS medicinal chemistry letters, , Dec-13, Volume: 3, Issue:12, 2012
SIRT1 modulation as a novel approach to the treatment of diseases of aging.Journal of medicinal chemistry, , Jan-27, Volume: 54, Issue:2, 2011
After the grape rush: sirtuins as epigenetic drug targets in neurodegenerative disorders.Bioorganic & medicinal chemistry, , Jun-15, Volume: 19, Issue:12, 2011
N(epsilon)-thioacetyl-lysine-containing tri-, tetra-, and pentapeptides as SIRT1 and SIRT2 inhibitors.Journal of medicinal chemistry, , Apr-09, Volume: 52, Issue:7, 2009
N-(3-(4-Hydroxyphenyl)-propenoyl)-amino acid tryptamides as SIRT2 inhibitors.Bioorganic & medicinal chemistry letters, , May-01, Volume: 17, Issue:9, 2007
Discovery of indoles as potent and selective inhibitors of the deacetylase SIRT1.Journal of medicinal chemistry, , Dec-15, Volume: 48, Issue:25, 2005
Synthesis and in Vitro and in Vivo Biological Evaluation of Tissue-Specific Bisthiazole Histone Deacetylase (HDAC) Inhibitors.Journal of medicinal chemistry, , 01-23, Volume: 63, Issue:2, 2020
Squaramides as novel class I and IIB histone deacetylase inhibitors for topical treatment of cutaneous t-cell lymphoma.Bioorganic & medicinal chemistry letters, , 09-15, Volume: 28, Issue:17, 2018
[no title available]Journal of medicinal chemistry, , 03-10, Volume: 65, Issue:5, 2022
Squaramides as novel class I and IIB histone deacetylase inhibitors for topical treatment of cutaneous t-cell lymphoma.Bioorganic & medicinal chemistry letters, , 09-15, Volume: 28, Issue:17, 2018
Single-step fluorescent probes to detect decrotonylation activity of HDACs through intramolecular reactions.European journal of medicinal chemistry, , Feb-15, Volume: 212, 2021
An overview of Sirtuins as potential therapeutic target: Structure, function and modulators.European journal of medicinal chemistry, , Jan-01, Volume: 161, 2019
Sirtuin inhibition and anti-cancer activities of ethyl 2-benzimidazole-5-carboxylate derivatives.MedChemComm, , Dec-01, Volume: 10, Issue:12, 2019
How much successful are the medicinal chemists in modulation of SIRT1: A critical review.European journal of medicinal chemistry, , Aug-25, Volume: 119, 2016
[no title available]Bioorganic & medicinal chemistry letters, , 11-01, Volume: 26, Issue:21, 2016
Benzimidazoles as new scaffold of sirtuin inhibitors: green synthesis, in vitro studies, molecular docking analysis and evaluation of their anti-cancer properties.European journal of medicinal chemistry, , Aug-18, Volume: 83, 2014
Aminothiazoles as Potent and Selective Sirt2 Inhibitors: A Structure-Activity Relationship Study.Journal of medicinal chemistry, , Feb-25, Volume: 59, Issue:4, 2016
[no title available]Bioorganic & medicinal chemistry letters, , 11-01, Volume: 26, Issue:21, 2016
Discovery of thieno[3,2-d]pyrimidine-6-carboxamides as potent inhibitors of SIRT1, SIRT2, and SIRT3.Journal of medicinal chemistry, , May-09, Volume: 56, Issue:9, 2013
The Discovery of Novel 10,11-Dihydro-5H-dibenz[b,f]azepine SIRT2 Inhibitors.MedChemComm, , Mar-01, Issue:3, 2012
Discovery of salermide-related sirtuin inhibitors: binding mode studies and antiproliferative effects in cancer cells including cancer stem cells.Journal of medicinal chemistry, , Dec-27, Volume: 55, Issue:24, 2012
SIRT1 modulation as a novel approach to the treatment of diseases of aging.Journal of medicinal chemistry, , Jan-27, Volume: 54, Issue:2, 2011
Characterization of sirtuin inhibitors in nematodes expressing a muscular dystrophy protein reveals muscle cell and behavioral protection by specific sirtinol analogues.Journal of medicinal chemistry, , Feb-11, Volume: 53, Issue:3, 2010
Enables
This protein enables 18 target(s):
Target | Category | Definition |
chromatin binding | molecular function | Binding to chromatin, the network of fibers of DNA, protein, and sometimes RNA, that make up the chromosomes of the eukaryotic nucleus during interphase. [GOC:jl, ISBN:0198506732, PMID:20404130] |
NAD+ ADP-ribosyltransferase activity | molecular function | Catalysis of the reaction: NAD+ + (ADP-D-ribosyl)(n)-acceptor = nicotinamide + (ADP-D-ribosyl)(n+1)-acceptor. [EC:2.4.2.30] |
histone deacetylase activity | molecular function | Catalysis of the reaction: histone N6-acetyl-L-lysine + H2O = histone L-lysine + acetate. This reaction represents the removal of an acetyl group from a histone, a class of proteins complexed to DNA in chromatin and chromosomes. [PMID:9893272, RHEA:58196] |
protein binding | molecular function | Binding to a protein. [GOC:go_curators] |
zinc ion binding | molecular function | Binding to a zinc ion (Zn). [GOC:ai] |
NAD-dependent histone deacetylase activity | molecular function | Catalysis of the reaction: histone N6-acetyl-L-lysine + H2O = histone L-lysine + acetate. This reaction requires the presence of NAD, and represents the removal of an acetyl group from a histone. [PMID:28450737] |
protein lysine deacetylase activity | molecular function | Catalysis of the reaction: H2O + N6-acetyl-L-lysyl-[protein] = acetate + L-lysyl-[protein]. [PMID:27296530, RHEA:58108] |
NAD-dependent protein lysine deacetylase activity | molecular function | Catalysis of the reaction: N(6)-acetyl-L-lysyl-[protein] + NAD+ + H2O = L-lysyl-[protein] + 2''-O-acetyl-ADP-D-ribose + nicotinamide. [GOC:BHF, GOC:mah, RHEA:43636] |
histone acetyltransferase binding | molecular function | Binding to an histone acetyltransferase. [GOC:bf] |
histone deacetylase binding | molecular function | Binding to histone deacetylase. [GOC:jl] |
tubulin deacetylase activity | molecular function | Catalysis of the reaction: N-acetyl(alpha-tubulin) + H2O = alpha-tubulin + acetate. [PMID:12024216, PMID:12486003] |
ubiquitin binding | molecular function | Binding to ubiquitin, a protein that when covalently bound to other cellular proteins marks them for proteolytic degradation. [GOC:ecd] |
NAD-dependent histone H4K16 deacetylase activity | molecular function | Catalysis of the reaction: histone H4 N6-acetyl-L-lysine (position 16) + H2O = histone H4 L-lysine (position 16) + acetate. This reaction requires the presence of NAD, and represents the removal of an acetyl group from lysine at position 16 of the histone H4 protein. [GOC:vw, PMID:28450737] |
NAD+ binding | molecular function | Binding to the oxidized form, NAD, of nicotinamide adenine dinucleotide, a coenzyme involved in many redox and biosynthetic reactions. [GOC:mah] |
DNA-binding transcription factor binding | molecular function | Binding to a DNA-binding transcription factor, a protein that interacts with a specific DNA sequence (sometimes referred to as a motif) within the regulatory region of a gene to modulate transcription. [GOC:txnOH-2018] |
NAD-dependent protein demyristoylase activity | molecular function | Catalysis of the reaction: N6-tetradecanoyl-L-lysyl-[protein] + NAD+ + H2O = tetradecanoyl-ADP-D-ribose + L-lysyl-[protein] + nicotinamide. [PMID:23552949, RHEA:70567] |
NAD-dependent protein depalmitoylase activity | molecular function | Catalysis of the reaction: N6-octadecanoyl-L-lysyl-[protein] + NAD+ + H2O = octadecanoyl-ADP-D-ribose + L-lysyl-[protein] + nicotinamide. [PMID:23552949, RHEA:70563] |
transcription factor binding | molecular function | Binding to a transcription factor, a protein required to initiate or regulate transcription. [ISBN:0198506732] |
Located In
This protein is located in 25 target(s):
Target | Category | Definition |
chromosome, telomeric region | cellular component | The end of a linear chromosome, required for the integrity and maintenance of the end. A chromosome telomere usually includes a region of telomerase-encoded repeats the length of which rarely exceeds 20 bp each and that permits the formation of a telomeric loop (T-loop). The telomeric repeat region is usually preceded by a sub-telomeric region that is gene-poor but rich in repetitive elements. Some telomeres only consist of the latter part (for eg. D. melanogaster telomeres). [GOC:elh] |
nucleus | cellular component | A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent. [GOC:go_curators] |
chromosome | cellular component | A structure composed of a very long molecule of DNA and associated proteins (e.g. histones) that carries hereditary information. [ISBN:0198547684] |
nucleolus | cellular component | A small, dense body one or more of which are present in the nucleus of eukaryotic cells. It is rich in RNA and protein, is not bounded by a limiting membrane, and is not seen during mitosis. Its prime function is the transcription of the nucleolar DNA into 45S ribosomal-precursor RNA, the processing of this RNA into 5.8S, 18S, and 28S components of ribosomal RNA, and the association of these components with 5S RNA and proteins synthesized outside the nucleolus. This association results in the formation of ribonucleoprotein precursors; these pass into the cytoplasm and mature into the 40S and 60S subunits of the ribosome. [ISBN:0198506732] |
cytoplasm | cellular component | The contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures. [ISBN:0198547684] |
mitochondrion | cellular component | A semiautonomous, self replicating organelle that occurs in varying numbers, shapes, and sizes in the cytoplasm of virtually all eukaryotic cells. It is notably the site of tissue respiration. [GOC:giardia, ISBN:0198506732] |
centrosome | cellular component | A structure comprised of a core structure (in most organisms, a pair of centrioles) and peripheral material from which a microtubule-based structure, such as a spindle apparatus, is organized. Centrosomes occur close to the nucleus during interphase in many eukaryotic cells, though in animal cells it changes continually during the cell-division cycle. [GOC:mah, ISBN:0198547684] |
centriole | cellular component | A cellular organelle, found close to the nucleus in many eukaryotic cells, consisting of a small cylinder with microtubular walls, 300-500 nm long and 150-250 nm in diameter. It contains nine short, parallel, peripheral microtubular fibrils, each fibril consisting of one complete microtubule fused to two incomplete microtubules. Cells usually have two centrioles, lying at right angles to each other. At division, each pair of centrioles generates another pair and the twin pairs form the pole of the mitotic spindle. [ISBN:0198547684] |
spindle | cellular component | The array of microtubules and associated molecules that forms between opposite poles of a eukaryotic cell during mitosis or meiosis and serves to move the duplicated chromosomes apart. [ISBN:0198547684] |
cytosol | cellular component | The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes. [GOC:hjd, GOC:jl] |
microtubule | cellular component | Any of the long, generally straight, hollow tubes of internal diameter 12-15 nm and external diameter 24 nm found in a wide variety of eukaryotic cells; each consists (usually) of 13 protofilaments of polymeric tubulin, staggered in such a manner that the tubulin monomers are arranged in a helical pattern on the microtubular surface, and with the alpha/beta axes of the tubulin subunits parallel to the long axis of the tubule; exist in equilibrium with pool of tubulin monomers and can be rapidly assembled or disassembled in response to physiological stimuli; concerned with force generation, e.g. in the spindle. [ISBN:0879693568] |
plasma membrane | cellular component | The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins. [ISBN:0716731363] |
growth cone | cellular component | The migrating motile tip of a growing neuron projection, where actin accumulates, and the actin cytoskeleton is the most dynamic. [GOC:aruk, GOC:bc, ISBN:0815316194, PMID:10082468] |
midbody | cellular component | A thin cytoplasmic bridge formed between daughter cells at the end of cytokinesis. The midbody forms where the contractile ring constricts, and may persist for some time before finally breaking to complete cytokinesis. [ISBN:0815316194] |
paranodal junction | cellular component | A highly specialized cell-cell junction found in vertebrates, which forms between a neuron and a glial cell, and has structural similarity to Drosophila septate junctions. It flanks the node of Ranvier in myelinated nerve and electrically isolates the myelinated from unmyelinated nerve segments and physically separates the voltage-gated sodium channels at the node from the cluster of potassium channels underneath the myelin sheath. [PMID:11395001, PMID:14630217] |
paranode region of axon | cellular component | An axon part that is located adjacent to the nodes of Ranvier and surrounded by lateral loop portions of myelin sheath. [GOC:mah, GOC:mh, NIF_Subcellular:sao936144858] |
perikaryon | cellular component | The portion of the cell soma (neuronal cell body) that excludes the nucleus. [GOC:jl] |
myelin sheath | cellular component | An electrically insulating fatty layer that surrounds the axons of many neurons. It is an outgrowth of glial cells: Schwann cells supply the myelin for peripheral neurons while oligodendrocytes supply it to those of the central nervous system. [GOC:cjm, GOC:jl, NIF_Subcellular:sao593830697, Wikipedia:Myelin] |
lateral loop | cellular component | Non-compact myelin located adjacent to the nodes of Ranvier in a myelin segment. These non-compact regions include cytoplasm from the cell responsible for synthesizing the myelin. Lateral loops are found in the paranodal region adjacent to the nodes of Ranvier, while Schmidt-Lantermann clefts are analogous structures found within the compact myelin internode. [GOC:dgh] |
Schmidt-Lanterman incisure | cellular component | Regions within compact myelin in which the cytoplasmic faces of the enveloping myelin sheath are not tightly juxtaposed, and include cytoplasm from the cell responsible for making the myelin. Schmidt-Lanterman incisures occur in the compact myelin internode, while lateral loops are analogous structures found in the paranodal region adjacent to the nodes of Ranvier. [GOC:dgh] |
juxtaparanode region of axon | cellular component | A region of an axon near a node of Ranvier that is between the paranode and internode regions. [GOC:BHF, GOC:jl, PMID:10624965, PMID:14682359] |
perinuclear region of cytoplasm | cellular component | Cytoplasm situated near, or occurring around, the nucleus. [GOC:jid] |
mitotic spindle | cellular component | A spindle that forms as part of mitosis. Mitotic and meiotic spindles contain distinctive complements of proteins associated with microtubules. [GOC:mah, GOC:vw, PMID:11408572, PMID:18367542, PMID:8027178] |
meiotic spindle | cellular component | A spindle that forms as part of meiosis. Several proteins, such as budding yeast Spo21p, fission yeast Spo2 and Spo13, and C. elegans mei-1, localize specifically to the meiotic spindle and are absent from the mitotic spindle. [GOC:mah, GOC:vw, PMID:11408572, PMID:18367542, PMID:8027178] |
glial cell projection | cellular component | A prolongation or process extending from a glial cell. [GOC:mc] |
Active In
This protein is active in 1 target(s):
Target | Category | Definition |
nucleus | cellular component | A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent. [GOC:go_curators] |
Part Of
This protein is part of 2 target(s):
Target | Category | Definition |
heterochromatin | cellular component | A compact and highly condensed form of chromatin that is refractory to transcription. [PMID:32017156] |
chromatin silencing complex | cellular component | Any protein complex that mediates changes in chromatin structure that result in transcriptional silencing. [GOC:mah] |
Involved In
This protein is involved in 47 target(s):
Target | Category | Definition |
negative regulation of transcription by RNA polymerase II | biological process | Any process that stops, prevents, or reduces the frequency, rate or extent of transcription mediated by RNA polymerase II. [GOC:go_curators, GOC:txnOH] |
rDNA heterochromatin formation | biological process | The formation of heterochromatin at ribosomal DNA, characterized by the modified histone H3K9me3. [PMID:10219245] |
protein deacetylation | biological process | The removal of an acetyl group from a protein amino acid. An acetyl group is CH3CO-, derived from acetic [ethanoic] acid. [GOC:ai] |
autophagy | biological process | The cellular catabolic process in which cells digest cellular materials, such as organelles and other macromolecular constituents, or non-self materials such as intracellular pathogens. Autophagy serves to provide essential nutrients under conditions of cellular stress; or can remodel intracellular structures during cell differentiation. [GOC:autophagy, ISBN:0198547684, PMID:11099404, PMID:29455577, PMID:9412464] |
mitotic nuclear membrane reassembly | biological process | The mitotic cell cycle process involving ESCRTIII that results in reformation of the nuclear envelope after mitotic nuclear division. In organisms undergoing closed mitosis this involves resealing or 'repair' of the nuclear envelope in the nuclear bridge. [PMID:26040712, PMID:28242692, PMID:32109380, PMID:32848252] |
regulation of exit from mitosis | biological process | Any process involved in the progression from anaphase/telophase to G1 that is associated with a conversion from high to low mitotic CDK activity. [GOC:rn] |
negative regulation of autophagy | biological process | Any process that stops, prevents, or reduces the frequency, rate or extent of autophagy. Autophagy is the process in which cells digest parts of their own cytoplasm. [GOC:dph, GOC:tb] |
negative regulation of peptidyl-threonine phosphorylation | biological process | Any process that decreases the frequency, rate or extent of peptidyl-threonine phosphorylation. Peptidyl-threonine phosphorylation is the phosphorylation of peptidyl-threonine to form peptidyl-O-phospho-L-threonine. [GOC:dph, GOC:tb] |
substantia nigra development | biological process | The progression of the substantia nigra over time from its initial formation until its mature state. The substantia nigra is the layer of gray substance that separates the posterior parts of the cerebral peduncles (tegmentum mesencephali) from the anterior parts; it normally includes a posterior compact part with many pigmented cells (pars compacta) and an anterior reticular part whose cells contain little pigment (pars reticularis). [GO_REF:0000021, GOC:cls, GOC:dgh, GOC:dph, GOC:jid, ISBN:0838580343, ISBN:0878937420] |
myelination in peripheral nervous system | biological process | The process in which neuronal axons and dendrites become coated with a segmented lipid-rich sheath (myelin) to enable faster and more energetically efficient conduction of electrical impulses. The sheath is formed by the cell membranes of Schwann cells in the peripheral nervous system. Adjacent myelin segments are separated by a non-myelinated stretch of axon called a node of Ranvier. [GO_REF:0000021, GOC:cls, GOC:dgh, GOC:dph, GOC:jid] |
heterochromatin formation | biological process | An epigenetic gene silencing mechanism in which chromatin is compacted into heterochromatin, resulting in a chromatin conformation refractory to transcription. This process starts with heterochromatin nucleation, its spreading, and ends with heterochromatin boundary formation. [PMID:25192661, PMID:33827924] |
subtelomeric heterochromatin formation | biological process | The compaction of chromatin into heterochromatin at the subtelomeric region. [GOC:mah, PMID:10219245, PMID:26205977] |
regulation of myelination | biological process | Any process that modulates the frequency, rate or extent of the formation of a myelin sheath around nerve axons. [GOC:mah] |
positive regulation of proteasomal ubiquitin-dependent protein catabolic process | biological process | Any process that activates or increases the frequency, rate or extent of the breakdown of a protein or peptide by hydrolysis of its peptide bonds, initiated by the covalent attachment of ubiquitin, and mediated by the proteasome. [GOC:mah] |
cellular response to oxidative stress | biological process | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of oxidative stress, a state often resulting from exposure to high levels of reactive oxygen species, e.g. superoxide anions, hydrogen peroxide (H2O2), and hydroxyl radicals. [GOC:mah] |
peptidyl-lysine deacetylation | biological process | The removal of an acetyl group from an acetylated lysine residue in a peptide or protein. [GOC:BHF, GOC:mah] |
epigenetic regulation of gene expression | biological process | A process that modulates the frequency, rate or extent of gene expression through chromatin remodeling either by modifying higher order chromatin fiber structure, nucleosomal histones, or cytosine methylation of DNA. Once established, this regulation may be maintained over many cell divisions. It can also be heritable in the absence of the instigating signal. [PMID:10521337, PMID:11498582, PMID:22243696, PMID:34414474] |
negative regulation of protein catabolic process | biological process | Any process that stops, prevents or reduces the frequency, rate or extent of protein catabolic process. [GO_REF:0000058, GOC:kmv, GOC:obol, GOC:TermGenie, PMID:24785082] |
regulation of phosphorylation | biological process | Any process that modulates the frequency, rate or extent of addition of phosphate groups into a molecule. [GOC:jl] |
proteasome-mediated ubiquitin-dependent protein catabolic process | biological process | The chemical reactions and pathways resulting in the breakdown of a protein or peptide by hydrolysis of its peptide bonds, initiated by the covalent attachment of ubiquitin, and mediated by the proteasome. [GOC:go_curators] |
positive regulation of DNA binding | biological process | Any process that increases the frequency, rate or extent of DNA binding. DNA binding is any process in which a gene product interacts selectively with DNA (deoxyribonucleic acid). [GOC:dph, GOC:jl, GOC:tb] |
post-translational protein modification | biological process | The process of covalently altering one or more amino acids in a protein after the protein has been completely translated and released from the ribosome. [GOC:jsg] |
cellular lipid catabolic process | biological process | The chemical reactions and pathways resulting in the breakdown of lipids, as carried out by individual cells. [GOC:jl] |
NLRP3 inflammasome complex assembly | biological process | The aggregation, arrangement and bonding together of a set of components to form the NLRP3 inflammasome complex, occurring at the level of an individual cell. [GOC:jl, PMID:21048113] |
innate immune response | biological process | Innate immune responses are defense responses mediated by germline encoded components that directly recognize components of potential pathogens. [GO_REF:0000022, GOC:add, GOC:ebc, GOC:mtg_sensu] |
negative regulation of fat cell differentiation | biological process | Any process that stops, prevents, or reduces the frequency, rate or extent of adipocyte differentiation. [GOC:go_curators] |
positive regulation of fatty acid biosynthetic process | biological process | Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of fatty acids. [GOC:go_curators] |
positive regulation of meiotic nuclear division | biological process | Any process that activates or increases the frequency, rate or extent of meiosis. [GOC:go_curators] |
negative regulation of striated muscle tissue development | biological process | Any process that stops, prevents, or reduces the frequency, rate or extent of striated muscle development. [GOC:go_curators] |
negative regulation of DNA-templated transcription | biological process | Any process that stops, prevents, or reduces the frequency, rate or extent of cellular DNA-templated transcription. [GOC:go_curators, GOC:txnOH] |
positive regulation of transcription by RNA polymerase II | biological process | Any process that activates or increases the frequency, rate or extent of transcription from an RNA polymerase II promoter. [GOC:go_curators, GOC:txnOH] |
cell division | biological process | The process resulting in division and partitioning of components of a cell to form more cells; may or may not be accompanied by the physical separation of a cell into distinct, individually membrane-bounded daughter cells. [GOC:di, GOC:go_curators, GOC:pr] |
meiotic cell cycle | biological process | Progression through the phases of the meiotic cell cycle, in which canonically a cell replicates to produce four offspring with half the chromosomal content of the progenitor cell via two nuclear divisions. [GOC:ai] |
regulation of cell cycle | biological process | Any process that modulates the rate or extent of progression through the cell cycle. [GOC:ai, GOC:dph, GOC:tb] |
response to redox state | biological process | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus indicating redox state. Redox state refers to the balance of oxidized versus reduced forms of electron donors and acceptors in an organelle, cell or organ; plastoquinone, glutathione (GSH/GSSG), and nicotinamide nucleotides (NAD+/NADH and NADP+/NADPH) are among the most important. [GOC:mah, PMID:15131240, PMID:16987039] |
positive regulation of cell division | biological process | Any process that activates or increases the frequency, rate or extent of cell division. [GOC:ai] |
positive regulation of attachment of spindle microtubules to kinetochore | biological process | Any process that activates or increases the frequency, rate or extent of the attachment of spindle microtubules to the kinetochore. [GOC:ai] |
cellular response to caloric restriction | biological process | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a of caloric restriction, insufficient food energy intake. [GOC:dph, PMID:17914901] |
negative regulation of oligodendrocyte progenitor proliferation | biological process | Any process that stops or decreases the rate or extent of oligodendrocyte progenitor proliferation. [GOC:mah, GOC:sl] |
cellular response to hypoxia | biological process | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus indicating lowered oxygen tension. Hypoxia, defined as a decline in O2 levels below normoxic levels of 20.8 - 20.95%, results in metabolic adaptation at both the cellular and organismal level. [GOC:mah] |
cellular response to epinephrine stimulus | biological process | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an epinephrine stimulus. Epinephrine is a catecholamine that has the formula C9H13NO3; it is secreted by the adrenal medulla to act as a hormone, and released by certain neurons to act as a neurotransmitter active in the central nervous system. [GOC:BHF, GOC:mah] |
tubulin deacetylation | biological process | The removal of an acetyl group from tubulin. An acetyl group is CH3CO-, derived from acetic [ethanoic] acid. [GOC:BHF, GOC:dph, GOC:tb] |
positive regulation of execution phase of apoptosis | biological process | Any process that activates or increases the frequency, rate or extent of execution phase of apoptosis. [GOC:mtg_apoptosis, GOC:TermGenie] |
positive regulation of oocyte maturation | biological process | Any process that activates or increases the frequency, rate or extent of oocyte maturation. [GOC:kmv, GOC:TermGenie] |
negative regulation of NLRP3 inflammasome complex assembly | biological process | Any process that stops, prevents or reduces the frequency, rate or extent of NLRP3 inflammasome complex assembly. [GOC:TermGenie] |
negative regulation of satellite cell differentiation | biological process | Any process that stops, prevents or reduces the frequency, rate or extent of satellite cell differentiation. [GO_REF:0000058, GOC:TermGenie, PMID:23212449] |
negative regulation of reactive oxygen species metabolic process | biological process | Any process that stops, prevents or reduces the frequency, rate or extent of reactive oxygen species metabolic process. [GOC:mah] |